When Practice Outpaces Evidence: Comparative Evidence for Stereotactic Ablative Radiotherapy Versus Surgical Resection for Stage I Non‑Small Cell Lung Cancer
Journal of Clinical Oncology · 03.11.2026
DOI: 10.1200/jco-26-01859 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Clinical Oncology, online erschienen am 03.11.2026. Verfasst von Brendon M Stiles. Beteiligte Einrichtung: Department of Cardiothoracic and Vascular Surgery, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Cardiothoracic and Vascular Surgery, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY.
ORCID-Profile: Brendon M Stiles
Zitieren
APA
Stiles, B. M. (2026). When Practice Outpaces Evidence: Comparative Evidence for Stereotactic Ablative Radiotherapy Versus Surgical Resection for Stage I Non‑Small Cell Lung Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-01859
Vancouver
Stiles BM. When Practice Outpaces Evidence: Comparative Evidence for Stereotactic Ablative Radiotherapy Versus Surgical Resection for Stage I Non‑Small Cell Lung Cancer. Journal of Clinical Oncology. 2026. doi:10.1200/jco-26-01859
BibTeX
@article{Stiles2026,
author = {Stiles, Brendon M},
title = {When Practice Outpaces Evidence: Comparative Evidence for Stereotactic Ablative Radiotherapy Versus Surgical Resection for Stage I Non‑Small Cell Lung Cancer},
journal = {Journal of Clinical Oncology},
year = {2026},
doi = {10.1200/jco-26-01859}
}
EUVIMED